Ownership of Human Tissues and Cells: New Developments in Biotechnology |
From inside the book
Results 1-5 of 91
Page
... Tissues and Cells New Developments in Biotechnology Office of Technology Assessment United States Congress Ownership of Human Tissues and Cells New Developments in Biotechnology. Ownership of Human Front Cover.
... Tissues and Cells New Developments in Biotechnology Office of Technology Assessment United States Congress Ownership of Human Tissues and Cells New Developments in Biotechnology. Ownership of Human Front Cover.
Page
... . Congress. Office of Technology Assessment. Ownership of Human Tissues and Cells New Developments in Biotechnology Books for Business New York - Hong Kong This One JLB9-22C - H976 Ownership of Human Tissues and Cells : New Developments in.
... . Congress. Office of Technology Assessment. Ownership of Human Tissues and Cells New Developments in Biotechnology Books for Business New York - Hong Kong This One JLB9-22C - H976 Ownership of Human Tissues and Cells : New Developments in.
Page
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Common terms and phrases
addition angiogenesis Angiogenin application approved benefits biomedical biotechnology blood cadaver cell culture cell line claim common law consent form consent process courts DHHS diagnostic disclose donations donor ethical factor Federal funded gene probes genetic Health human biological materials human body human research human subjects human tissues hybridoma immune individual informed consent institution Institutional Review Board Interferon Interleukin-2 inventions investigator involving isolated issues liability lymphocyte lymphokines ment mercial molecule monoclonal antibodies moral nonprofit obtained Office of Technology Organ Transplantation organs participation patient payments to sources physician plaintiff potential commercial gain principle procedures protection protein recombinant DNA regulations relationship Res Nullius research subjects result risks sample specific specimens statute substance Supp techniques Technology Assessment terials therapeutic tion tissues and cells tissues or cells tort trade secret transplantation treatment tumor types U.S. Congress University waive